QMSR for MedTech Startups: What Changed for Design Controls in 2026
QMSR took effect February 2, 2026, and FDA now reads design controls through ISO 13485 and a risk-first inspection model. Here is a seven-point checklist MedTech startups can use to get design controls QMSR-ready.
Medical Device Commercialization Readiness: What Investors Expect in 2026
Medtech venture capital in 2026 is flowing to de-risked programs. Here are seven commercialization readiness questions medical device founders should answer before the next raise, from design inputs and FDA pathway to manufacturability.
A Question for MedTech Founders: When Did You Start Thinking About Manufacturing?
A working prototype is not automatically a scalable product. Here is why medical device founders should think about tolerances, inspection, supply chain and automation long before production.
The Hidden Costs of Medical Device Development
The most underestimated cost in medical device development is not engineering. It is the cascade of late design changes, and most of it can be prevented with earlier cross-functional planning.
Fractional Leadership for MedTech Startups
Many medical device startups do not need a full-time executive team yet, but they do need experienced program leadership. Here is what a fractional program leader does and when to bring one in.
For Early-Stage MedTech Founders: What Should You Focus on Next?
Early-stage medical device founders face many urgent choices at once. A development roadmap across product, regulatory, clinical and manufacturing strategy shows what to tackle first.
The #1 Mistake MedTech Startups Make: Waiting Too Long to Plan for Manufacturing
Many medical device startups wait too long to plan for manufacturing. Here is how design for manufacturability, early supplier engagement and automation strategy close the prototype-to-production gap.